Cobalamin conjugates useful as imaging and therapeutic agents

Details Cobalamin conjugates useful as imaging and therapeutic agents Cobalamin conjugates useful as imaging and therapeutic agents

2005-01-04

2005-01-04

Jones, Dameron L. (Department: 1616)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

C424S001110, C424S001650, C424S009100, C424S001810, C424S001730, C534S010000, C534S014000, C536S026400

Reexamination Certificate

active

06838073

ABSTRACT:
The invention provides detectably labeled cobalamin derivatives which are useful for medical treatment and diagnosis.

REFERENCES:
patent: 3936440 (1976-02-01), Nath
patent: 3981863 (1976-09-01), Niswender et al.
patent: 4209614 (1980-06-01), Bernstein et al.
patent: 4279859 (1981-07-01), Gutcho et al.
patent: 4283342 (1981-08-01), Yollees
patent: 4301140 (1981-11-01), Frank et al.
patent: 4465775 (1984-08-01), Houts
patent: 4612302 (1986-09-01), Szabo et al.
patent: 4684620 (1987-08-01), Hruby et al.
patent: 4853371 (1989-08-01), Coy et al.
patent: 5308606 (1994-05-01), Wilson et al.
patent: 5405839 (1995-04-01), Toraya et al.
patent: 5428023 (1995-06-01), Russell-Jones et al.
patent: 5449720 (1995-09-01), Russell-Jones et al.
patent: 5548064 (1996-08-01), Russell-Jones et al.
patent: 5559796 (1996-09-01), Edem et al.
patent: 5574018 (1996-11-01), Habberfield et al.
patent: 5589463 (1996-12-01), Russell-Jones et al.
patent: 5608060 (1997-03-01), Axworthy et al.
patent: 5739313 (1998-04-01), Collins et al.
patent: 5807832 (1998-09-01), Russell-Jones et al.
patent: 5840880 (1998-11-01), Morgan et al.
patent: 5869465 (1999-02-01), Morgan et al.
patent: 5869466 (1999-02-01), Russell-Jones et al.
patent: 5877165 (1999-03-01), Miura
patent: 5936082 (1999-08-01), Bauer
patent: 6004533 (1999-12-01), Collins et al.
patent: 6074625 (2000-06-01), Hawthorne et al.
patent: 6083926 (2000-07-01), Morgan et al.
patent: 6096290 (2000-08-01), Collins et al.
patent: 6150341 (2000-11-01), Russell-Jones et al.
patent: 6211355 (2001-04-01), Collins et al.
patent: 6262253 (2001-07-01), Russell-Jones et al.
patent: 6315978 (2001-11-01), Grissom et al.
patent: 0 005 834 (1979-12-01), None
patent: 0 069450 (1983-01-01), None
patent: 0 165 716 (1985-12-01), None
patent: 58-046027 (1983-03-01), None
patent: WO 8901475 (1989-02-01), None
patent: WO 9213571 (1992-08-01), None
patent: WO 9427613 (1994-12-01), None
patent: WO 9427641 (1994-12-01), None
patent: WO 9527723 (1995-10-01), None
patent: WO 9631243 (1996-10-01), None
patent: WO 9714711 (1997-04-01), None
patent: WO 9718231 (1997-05-01), None
patent: WO 9733627 (1997-09-01), None
patent: WO 9808859 (1998-03-01), None
patent: WO 9965930 (1999-12-01), None
patent: WO 0045857 (2000-08-01), None
patent: WO 0062808 (2000-10-01), None
patent: WO 00145857 (2000-10-01), None
patent: WO 0074721 (2000-12-01), None
patent: WO 0130967 (2001-05-01), None
Smeltzer, et al., Synthesis and Characterization of Fluorescent Cobalamin (CobalaFluor) Derivatives for Imaging,Organic Letters, vol. 3, No. 6, pp. 799-801, (2001).
U.S. patent application Ser. No. 09/690,197, Collins et al., filed Oct. 16, 2000.
U.S. patent application Ser. No. 09/690,198, Collins et al., filed Oct. 16, 2000.
U.S. patent application Ser. No. 09/626,213, Collins et al., filed Oct. 16, 2001.
U.S. patent application Ser. No. 09/873,142, Collins et al., filed May 31, 2001.
U.S. patent application Ser. No. 09/873,164, Collins et al., filed May 31, 2001.
U.S. patent application Ser. No. 10/028,857, Collins et al., filed Oct. 25, 2001.
U.S. patent application Ser. No. 10/027,593, Collins et al., filed Oct. 25, 2001.
Wilbur, et al., “Biotin Reagents for Antibody Pretargeting. 4. Selection of Biotin Conjugates for in Vivo. Application Based on Their Dissociation Rate from Avidin and Streptavidin.”Bioconjugate Chem., 11(4), 569-583 (Jun. 29, 2000).
Wilbur, et al., “Evaluation of Biotin-Dye Conjugates for Use in an HPLC Assay to Assess Relative Binding of Biotin Derivatives with Avidin and Streptavidin.”Bioconjugate Chem., 11(4), 584-598 (Jun. 29, 2000).
Alam et al., Strahlentherapie und Onkologie; 165 (1989), 121-123.
Amagasaki et al., Blood, 76:7, 1380-1386, (1990).
Anton et al., The J. of Biol. Chem. 255:10 of May 25, pp. 4507-4510 (1980).
Begly et al.,J. Cell Physiol., 156, 43-47 (1993).
Blomquist et al.,Experientia, 25, 294-296 (1969).
Clinical Experience of Boron-Neutron Capture Therapy for Gliomas-A Comparison with Conventional Chemo-Immuno-Radiotherapy(undated).
Cooper et al.,Nature, 191, 393-395 (1961).
Collins et al.,Mayo Clinic Proc., 74, 687-691 (1999).
Collins et al.,J. Nucl. Med., 38:5, 717-723 (1997).
Gabel,Tumor Seeking Compounds for Born Neutron Capture Therapy: Syntesis nd Biodistribution, Clinical Aspects of Neutron Capture Therapy (undated) (Fairchild ed.).
Fairchild et al.,International Journal of Radiation Oncology, Biology, Physics, vol. 11, No. 1-4 (1985) pp. 1-882.
Flodh et al.,Int. J. Cancer: 3, 694-699 (1968).
Gabel et al., Radiation Research, vol. 111, 14-25, 1987.
Hatanaka,Journal of Neurology, vol. 209, 81-94 (1975).
Hawthorne et al.,Journal of Medical Chemistry, vol. 15, No. 5, 1972.
Hogenkamp et al.,Biochemistry, 13:13, 2736-2739 (1974).
Hogenkamp, et al.Nucl. Med. and Biol., 27, 89-92 (2000).
Ichihashi, et al., The Journal of Investigative Dermatology, vol. 78, No. 3 (1982).
Kulh, et al.,Chemical and Biological Studies on Boronated Tetraphenyl Porphyrins, Boron Chemistry.
(Mishima), The Lancet,Treatment of Malignant Melanoma by Single Thermal Neutron Capture Therapy with Melanoma-Seeking B-Compounds, p. 388, Aug. 12, 1989.
Laster et al.,Strahlentherapie und Onkologie, 165 (1989), 203-205.
Lindemans, et al.,Experimental Cell Research, 184:2, Oct. 1989.
Mishima et al.,Strahlentherapie Und Onkologie, 165 (1989) 251-254.
Nakagawa et al.,Chem. Pharm. Bull., Jul. 18, 1975, UDC 547.869.2.04; 547. 244.04.

Affiliated with

Also associated with

Rating

Cobalamin conjugates useful as imaging and therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cobalamin conjugates useful as imaging and therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cobalamin conjugates useful as imaging and therapeutic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3371312